Nutrition is a vital part of public health, yet access to good quality food for low-income individuals can be problematic.
That is why The Duke Outpatient Clinic (DOC) decided to start the Fresh Produce Program (FPP), where the Clinic provides fruit, vegetables, and other staples to food-...
Jenny Van Kirk, MD, currently the chief medical resident for Duke University Hospital, will serve as the associate director of Undergraduate Medical Education (UME) for the Department of Medicine as well as assistant program director for the Internal Medicine Residency Program, effective July 1, 2019.
When a woman with rheumatic disease is pregnant, she may experience many symptoms--some from her underlying disease and some from pregnancy itself. Which of these symptoms signal increased risk for preterm delivery?
Nathaniel Harris, MD, PhD, an intern in the Duke internal medicine residency program, spent his third year of medical school, also at Duke, plumbing the DAP registry for insights into this question.
The Department of Medicine has awarded the 2019 Chair's Research Award to four junior investigators who are making the transition to becoming independent scientists prior to their acquisition of extramural funding.
Megan Clowse, MD, MPH, is excited about a new development in the Duke Lupus Clinic that has opened up new ways of understanding, treating, and talking about lupus.
In her clinic, Megan Clowse, MD, MPH, associate professor of medicine (Rheumatology and Immunology), helps patients with rheumatic disease safely navigate pregnancy while managing their disease. In her research, she gathers and analyzes data about the best pregnancy planning and management practices. She’s also working to educate providers and patients on a larger scale.
“I’m trying to figure out how everyone can get state-of-the-art care from their local rheumatologist in order to have healthy pregnancies,” she says. “My mission is that all women with rheumatic disease can have the families they want.”
Two Department Medicine faculty members were inducted into the Association of American Physicians (AAP) during a joint April 6 meeting of the AAP, the American Society for Clinical Investigation (ASCI) and the American Physician-Scientists Association (APSA...
For women who take hydroxychloroquine (HCQ) to control rheumatic disease, research has shown that it’s best for mother and baby to continue the medicine during pregnancy. But should the dose be maintained, decreased, or increased? Stephen Balevic, MD, assistant professor of pediatrics and medicine (Rheumatology and Immunology), set out to investigate this question using data from the Duke Autoimmunity in Pregnancy registry.